Application Nr Approved Date Route Status External Links
NDA021875 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Armodafinil Is Indicated To Improve Wakefulness In Adult Patients With Excessive Sleepiness Associated With Obstructive Sleep Apnea (Osa), Narcolepsy, Or Shift Work Disorder (Swd). Limitations Of Use In Osa, Armodafinil Is Indicated To Treat Excessive Sleepiness And Not As Treatment For The Underlying Obstruction. If Continuous Positive Airway Pressure (Cpap) Is The Treatment Of Choice For A Patient, A Maximal Effort To Treat With Cpap For An Adequate Period Of Time Should Be Made Prior To Initiating Armodafinil For Excessive Sleepiness. Armodafinil Is Indicated To Improve Wakefulness In Adult Patients With Excessive Sleepiness Associated With Obstructive Sleep Apnea (Osa), Narcolepsy, Or Shift Work Disorder (Swd). ( 1 ) Limitations Of Use In Osa, Armodafinil Is Indicated To Treat Excessive Sleepiness And Not As Treatment For The Underlying Obstruction.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Armodafinil ARMODAFINIL ZINC3831139

Comments